 WALTHAM, Mass., Jan. 09, 2023 GLOBE NEWSWIRE CinCor Pharma, Inc. NASDAQ: CINC today announced that it has entered into a definitive agreement with AstraZeneca under which AstraZeneca has agreed to acquire CinCor. Marc de Garidel, Chief Executive Officer at CinCor, said: We are excited about the proposed acquisition of CinCor Pharma by AstraZeneca as ... The post CinCor Pharma to be Acquired by AstraZeneca appeared first on ForexTV... 